The Synthetic LXR Agonist GW3965 Attenuates Phosgene‐Induced Acute Lung Injury Through the Modulation of PI3K/Akt and NF‐κB Signalling Pathways
Basic & Clinical Pharmacology & Toxicology · 2025
DOI: 10.1111/bcpt.70045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2025. Verfasst von Dong Yan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Department, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Liver X Receptors, Acute Lung Injury, Benzylamines, Phosgene. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Phosgene, used in large‐scale industrial production, is highly toxic and irritant. Accidental exposure can lead to varying degrees of injuries, with severe cases potentially resulting in acute lung injury or acute respiratory distress syndrome, resulting in a mortality rate of 40%–50%. The indirect damages of phosgene (inflammation and oxidative stress) are considered important factors in phosgene‐induced acute lung injury (P‐ALI). The expression of Liver X Receptor α (LXRα) significantly reduces during periods of inflammation. LXRs were initially discovered to be highly expressed in the liver, whereas LXRs are expressed in immune cells and vascular endothelial cells, playing a significant role in anti‐inflammatory and antioxidant responses. LXRα may have pulmonary protection in P‐ALI. However, evidence to verify this association is still lacking. In this study, rats were divided into six groups to explore the potential role of LXRα in P‐ALI. This study found that GW3965 effectively activated LXRα, upregulated its expression and downregulated the levels of proinflammatory cytokines, inhibited malondialdehyde activity while enhancing superoxide dismutase activity, suppressed apoptosis and ameliorated the pathological processes of P‐ALI, ultimately exerting pulmonary protection in P‐ALI. Further validation revealed that the pulmonary protective effect of LXRα may be associated with the PI3K/Akt and NF‐kB signalling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Emergency Department, Peking University Third Hospital, Beijing, China.
- Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Beijing, China.
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.
- Department of Occupational Disease, Peking University Third Hospital, Beijing, China.
ORCID-Profile: Dong Yan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yan, D., Fu, Y., Mei, J., Wang, J., Jiamaliding, A., Liu, Y., Zhao, Z., & Ma, Q. (2025). The Synthetic LXR Agonist GW3965 Attenuates Phosgene‐Induced Acute Lung Injury Through the Modulation of PI3K/Akt and NF‐κB Signalling Pathways. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70045
Vancouver
Yan D, Fu Y, Mei J, Wang J, Jiamaliding A, Liu Y, et al. The Synthetic LXR Agonist GW3965 Attenuates Phosgene‐Induced Acute Lung Injury Through the Modulation of PI3K/Akt and NF‐κB Signalling Pathways. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.70045
BibTeX
@article{Yan2025,
author = {Yan, Dong and Fu, Yuanwei and Mei, Jie and Wang, Junhong and Jiamaliding, Ayijiang and Liu, Ying and Zhao, Zanmei and Ma, Qingbian},
title = {The Synthetic LXR Agonist GW3965 Attenuates Phosgene‐Induced Acute Lung Injury Through the Modulation of PI3K/Akt and NF‐κB Signalling Pathways},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
doi = {10.1111/bcpt.70045}
}
EUVIMED